ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 623084 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 623084; 2) Community: the network communities that were significantly associated with the response to NSC 623084; 3) Molecule: the relationships between components within communities and NSC 623084; 4) MDR: the compounds that were significantly associated with the NSC 623084.

NSC Compound Enrichment Correlation
NSC 668281 (-)-.beta.-L-1-[(2-Hydroxymethyl)-1,3-dioxolan-4yl]cytosine 0.0133986477026051 0.31428398
NSC 749076 3-(7-methoxy-3-methyl-1,4-dioxy-quinoxalin-2-yl)-1-(3,4,5-trimethoxy-phenyl)-propenone 0.0133986477026051 0.39253334
NSC 85701 Quinolinium, 6-ethoxy-2-[2-(8-hydroxy-5-quinolyl)vinyl]-1-methyl- iodide 0.0133986477026051 0.011065871
NSC 92988 Null 0.0133986477026051 0.23232529
NSC 373355 Saframycin R 0.0133986477026052 0.2289544
NSC 529108 4-Fluoro-D,L-tryptophan 0.0133986477026052 0.16821186
NSC 638624 Null 0.0137891122538509 0.019120907
NSC 63878 Cytarabine Hydrochloride AZ 0.0137891122538509 0.29494253
NSC 683766 Benzoic acid, 4-[[(2-bromi-3,6-dioxo-1,4-cyclohexadienyl)methyl]-amino]-, 1-adamantyl ester 0.0137891122538509 0.19629765
NSC 687578 Null 0.0137891122538509 0.23096631
Total:57  Current:19    [First] [Prev] [Next] [Last]